Alert! Zenabis COVID-19, golden opportunity The investment landscape has dramatically changed in recent months as global markets responded to the Covid-19 crisis. Add to that a US election season, simmering global trade tensions, wild swings in commodity markets, and social unrest, and many investors have been left at a loss on what to do next in such a volatile and uncertain environment. Enter Zenabis, TSX: ZENA.
Zenabis just hired a new CEO who headed up McCain Canada and before that Mars Wrigley. As Zenabis emerges from growth/financing stage with strong share structure intact, the company will draw from growing cash flow to execute on its strategy with partners, including Tilray, Shoppers Drug Mart, and many others. At a present market cap of $60M, Zenabis, formerly a $1.1B company, is poised to become a cash cow and stalwart fixture in the global cannabis landscape. Q1/2020 has positive EBITDA signalling that the ship has been righted. Investors eagerly await Q2/2020 results next week. Don't wait until this stock is 35 cents to get in.